{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["TERT promoter mutation", "glioma", "immune checkpoint blockade therapy", "immunity", "risk model"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38499392", "DateCompleted": {"Year": "2024", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "02"}, "Article": {"Language": ["eng"], "ELocationID": ["10.18632/aging.205668"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "18"}], "Journal": {"ISSN": "1945-4589", "JournalIssue": {"Volume": "16", "Issue": "6", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "18"}}, "Title": "Aging", "ISOAbbreviation": "Aging (Albany NY)"}, "ArticleTitle": "Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.", "Pagination": {"StartPage": "5618", "EndPage": "5633", "MedlinePgn": "5618-5633"}, "Abstract": {"AbstractText": ["The telomerase reverse transcriptase promoter (TERTp) is frequently mutated in gliomas. This study sought to identify immune biomarkers of gliomas with TERTp mutations. Data from TCGA were used to identify and validate survival-associated gene signatures, and immune and stromal scores were calculated using the ESTIMATE algorithm. High stromal or immune scores in patients with TERTp-mutant gliomas correlated with shorter overall survival compared to cases with low stromal or immune scores. Among TERTp-mutant gliomas with both high immune and high stromal scores, 213 commonly shared DEGs were identified. Among 71 interacting DEGs representing candidate hub genes in a PPI network, HOXC6, WT1, CD70, and OTP showed significant ability in establishing subgroups of high- and low-risk patients. A risk model based on these 4 genes showed strong prognostic potential for gliomas with mutated TERTp, but was inapplicable for TERTp-wild-type gliomas. TERTp-mutant gliomas with high-risk scores displayed a greater percentage of na\u00efve B cells, plasma cells, na\u00efve CD4 T cells, and activated mast cells than low-risk score gliomas. TIDE analysis indicated that immune checkpoint blockade (ICB) therapy may benefit glioma patients with TERTp mutations. The present risk model can help predict prognosis of glioma patients with TERTp mutations and aid ICB treatment options."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Cao", "ForeName": "Wenpeng", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, Guizhou 550004, China."}], "LastName": "Lan", "ForeName": "Jinzhi", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&amp;D, Guiyang, Guizhou 550025, China."}], "LastName": "Hu", "ForeName": "Chujiao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Kong", "ForeName": "Jinping", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Xiang", "ForeName": "Limin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Zhang", "ForeName": "Zhixue", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Sun", "ForeName": "Yating", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Zeng", "ForeName": "Zhirui", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Lei", "ForeName": "Shan", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Aging (Albany NY)", "NlmUniqueID": "101508617", "ISSNLinking": "1945-4589"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Immune Checkpoint Inhibitors"}, {"RegistryNumber": "EC 2.7.7.49", "NameOfSubstance": "Telomerase"}, {"RegistryNumber": "EC 2.7.7.49", "NameOfSubstance": "TERT protein, human"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Immune Checkpoint Inhibitors"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Brain Neoplasms"}, {"QualifierName": [], "DescriptorName": "Mutation"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Glioma"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": ["genetics"], "DescriptorName": "Telomerase"}], "CoiStatement": "<b>CONFLICTS OF INTEREST:</b> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "De Silva MI, Stringer BW, Bardy C. Neuronal and tumourigenic boundaries of glioblastoma plasticity. Trends Cancer. 2023; 9:223\u201336. 10.1016/j.trecan.2022.10.010", "ArticleIdList": ["10.1016/j.trecan.2022.10.010", "36460606"]}, {"Citation": "Nicholson JG, Fine HA. Diffuse Glioma Heterogeneity and Its Therapeutic Implications. Cancer Discov. 2021; 11:575\u201390. 10.1158/2159-8290.CD-20-1474", "ArticleIdList": ["10.1158/2159-8290.CD-20-1474", "33558264"]}, {"Citation": "Nejo T, Yamamichi A, Almeida ND, Goretsky YE, Okada H. Tumor antigens in glioma. Semin Immunol. 2020; 47:101385. 10.1016/j.smim.2020.101385", "ArticleIdList": ["10.1016/j.smim.2020.101385", "32037183"]}, {"Citation": "Sun Z, Zhao Y, Wei Y, Ding X, Tan C, Wang C. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma. Front Immunol. 2022; 13:939523. 10.3389/fimmu.2022.939523", "ArticleIdList": ["10.3389/fimmu.2022.939523", "PMC9452727", "36091049"]}, {"Citation": "McAleenan A, Jones HE, Kernohan A, Robinson T, Schmidt L, Dawson S, Kelly C, Spencer Leal E, Faulkner CL, Palmer A, Wragg C, Jefferies S, Brandner S, et al.. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma. Cochrane Database Syst Rev. 2022; 3:CD013387. 10.1002/14651858.CD013387.pub2", "ArticleIdList": ["10.1002/14651858.CD013387.pub2", "PMC8889390", "35233774"]}, {"Citation": "Fujimoto K, Arita H, Satomi K, Yamasaki K, Matsushita Y, Nakamura T, Miyakita Y, Umehara T, Kobayashi K, Tamura K, Tanaka S, Higuchi F, Okita Y, et al.. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. Acta Neuropathol. 2021; 142:323\u201338. 10.1007/s00401-021-02337-9", "ArticleIdList": ["10.1007/s00401-021-02337-9", "34148105"]}, {"Citation": "Thomas C, Thierfelder F, Tr\u00e4ger M, Soschinski P, M\u00fcther M, Edelmann D, F\u00f6rster A, Geiler C, Kim HY, Filipski K, Harter PN, Schittenhelm J, Eckert F, et al.. TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma. Acta Neuropathol. 2021; 141:959\u201370. 10.1007/s00401-021-02300-8", "ArticleIdList": ["10.1007/s00401-021-02300-8", "PMC8113189", "33755803"]}, {"Citation": "Dratwa M, Wysocza\u0144ska B, \u0141acina P, Kubik T, Bogunia-Kubik K. TERT-Regulation and Roles in Cancer Formation. Front Immunol. 2020; 11:589929. 10.3389/fimmu.2020.589929", "ArticleIdList": ["10.3389/fimmu.2020.589929", "PMC7717964", "33329574"]}, {"Citation": "Olympios N, Gilard V, Marguet F, Clatot F, Di Fiore F, Fontanilles M. TERT Promoter Alterations in Glioblastoma: A Systematic Review. Cancers (Basel). 2021; 13:1147. 10.3390/cancers13051147", "ArticleIdList": ["10.3390/cancers13051147", "PMC7962450", "33800183"]}, {"Citation": "Appin CL, Brat DJ. Biomarker-driven diagnosis of diffuse gliomas. Mol Aspects Med. 2015; 45:87\u201396. 10.1016/j.mam.2015.05.002", "ArticleIdList": ["10.1016/j.mam.2015.05.002", "26004297"]}, {"Citation": "Guterres AN, Villanueva J. Targeting telomerase for cancer therapy. Oncogene. 2020; 39:5811\u201324. 10.1038/s41388-020-01405-w", "ArticleIdList": ["10.1038/s41388-020-01405-w", "PMC7678952", "32733068"]}, {"Citation": "Chen C, Han S, Meng L, Li Z, Zhang X, Wu A. TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas. PLoS One. 2014; 9:e100297. 10.1371/journal.pone.0100297", "ArticleIdList": ["10.1371/journal.pone.0100297", "PMC4061075", "24937153"]}, {"Citation": "Gao M, Lin Y, Liu X, Zhao Z, Zhu Z, Zhang H, Ban Y, Bie Y, He X, Sun X, Zhang S. TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma. Front Cell Dev Biol. 2021; 9:654407. 10.3389/fcell.2021.654407", "ArticleIdList": ["10.3389/fcell.2021.654407", "PMC8119999", "33996815"]}, {"Citation": "Mondia MWL, Kritselis MA, Donahue JE, Elinzano H, Sarangi S, Bryant D, Capelletti M, Korn WM, Yu E, Yan S, Toms SA, Wong ET. Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selection. Front Neurol. 2023; 13:1017087. 10.3389/fneur.2022.1017087", "ArticleIdList": ["10.3389/fneur.2022.1017087", "PMC9871816", "36703629"]}, {"Citation": "Jimenez-Garc\u00eda MP, Lucena-Cacace A, Otero-Albiol D, Carnero A. Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2. Cell Death Dis. 2021; 12:515. 10.1038/s41419-021-03801-w", "ArticleIdList": ["10.1038/s41419-021-03801-w", "PMC8137939", "34016958"]}, {"Citation": "Rudzi\u0144ska M, Czarnocka B. The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy. Int J Mol Sci. 2020; 21:3220. 10.3390/ijms21093220", "ArticleIdList": ["10.3390/ijms21093220", "PMC7247360", "32370142"]}, {"Citation": "Yan TF, Wu MJ, Xiao B, Hu Q, Fan YH, Zhu XG. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo. Pathol Res Pract. 2018; 214:1818\u201324. 10.1016/j.prp.2018.09.001", "ArticleIdList": ["10.1016/j.prp.2018.09.001", "30228024"]}, {"Citation": "Eryi S, Zheng L, Honghua C, Su Z, Han X, Donggang P, Zhou Z, Liping Z, Bo C. HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-\u03b2/Smad Signaling Pathway and Predicts a Poor Prognosis in Glioblastoma. J Oncol. 2022; 2022:8016102. 10.1155/2022/8016102", "ArticleIdList": ["10.1155/2022/8016102", "PMC9098331", "35571491"]}, {"Citation": "Huang H, Huo Z, Jiao J, Ji W, Huang J, Bian Z, Xu B, Shao J, Sun J. HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas. Cancer Cell Int. 2022; 22:170. 10.1186/s12935-022-02589-9", "ArticleIdList": ["10.1186/s12935-022-02589-9", "PMC9052479", "35488304"]}, {"Citation": "Simeone A, D'Apice MR, Nigro V, Casanova J, Graziani F, Acampora D, Avantaggiato V. Orthopedia, a novel homeobox-containing gene expressed in the developing CNS of both mouse and Drosophila. Neuron. 1994; 13:83\u2013101. 10.1016/0896-6273(94)90461-8", "ArticleIdList": ["10.1016/0896-6273(94)90461-8", "7913821"]}, {"Citation": "Hanley KZ, Dureau ZJ, Cohen C, Shin DM, Owonikoko TK, Sica GL. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung. Cancer Cytopathol. 2018; 126:236\u201342. 10.1002/cncy.21969", "ArticleIdList": ["10.1002/cncy.21969", "29316326"]}, {"Citation": "Swarts DR, Henfling ME, Van Neste L, van Suylen RJ, Dingemans AM, Dinjens WN, Haesevoets A, Rudelius M, Thunnissen E, Volante M, Van Criekinge W, van Engeland M, Ramaekers FC, Speel EJ. CD44 and OTP are strong prognostic markers for pulmonary carcinoids. Clin Cancer Res. 2013; 19:2197\u2013207. 10.1158/1078-0432.CCR-12-3078", "ArticleIdList": ["10.1158/1078-0432.CCR-12-3078", "23444222"]}, {"Citation": "Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N, Han H, Chokshi C, Kuhlmann L, et al.. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. J Immunother Cancer. 2022; 10:e003289. 10.1136/jitc-2021-003289", "ArticleIdList": ["10.1136/jitc-2021-003289", "PMC8753449", "35017149"]}, {"Citation": "Ge H, Mu L, Jin L, Yang C, Chang YE, Long Y, DeLeon G, Deleyrolle L, Mitchell DA, Kubilis PS, Lu D, Qi J, Gu Y, et al.. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM. Int J Cancer. 2017; 141:1434\u201344. 10.1002/ijc.30830", "ArticleIdList": ["10.1002/ijc.30830", "28612394"]}, {"Citation": "Jin L, Ge H, Long Y, Yang C, Chang YE, Mu L, Sayour EJ, De Leon G, Wang QJ, Yang JC, Kubilis PS, Bao H, Xia S, et al.. CD70, a novel target of CAR T-cell therapy for gliomas. Neuro Oncol. 2018; 20:55\u201365. 10.1093/neuonc/nox116", "ArticleIdList": ["10.1093/neuonc/nox116", "PMC5761579", "28651374"]}, {"Citation": "Wang W, Wang J, Yang C, Wang J. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis. IUBMB Life. 2021; 73:866\u201382. 10.1002/iub.2468", "ArticleIdList": ["10.1002/iub.2468", "33759343"]}, {"Citation": "Wu Z, Qiu M, Mi Z, Meng M, Guo Y, Jiang X, Fang J, Wang H, Zhao J, Liu Z, Qian D, Yuan Z. WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/FOXO1 axis. Mol Oncol. 2019; 13:1059\u201374. 10.1002/1878-0261.12462", "ArticleIdList": ["10.1002/1878-0261.12462", "PMC6487700", "30690883"]}, {"Citation": "Chiba Y, Hashimoto N, Tsuboi A, Rabo C, Oka Y, Kinoshita M, Kagawa N, Oji Y, Sugiyama H, Yoshimine T. Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients. Brain Tumor Pathol. 2010; 27:29\u201334. 10.1007/s10014-010-0265-9", "ArticleIdList": ["10.1007/s10014-010-0265-9", "20425045"]}, {"Citation": "Yokota C, Kagawa N, Takano K, Chiba Y, Kinoshita M, Kijima N, Oji Y, Oka Y, Sugiyama H, Tsuboi A, Izumoto S, Kishima H, Hashimoto N. Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy. Cancer Immunol Immunother. 2022; 71:189\u2013201. 10.1007/s00262-021-02954-z", "ArticleIdList": ["10.1007/s00262-021-02954-z", "PMC10991314", "34089373"]}, {"Citation": "Xiao Z, Dai Z, Locasale JW. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat Commun. 2019; 10:3763. 10.1038/s41467-019-11738-0", "ArticleIdList": ["10.1038/s41467-019-11738-0", "PMC6704063", "31434891"]}, {"Citation": "Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci. 2016; 19:20\u20137. 10.1038/nn.4185", "ArticleIdList": ["10.1038/nn.4185", "PMC4876023", "26713745"]}, {"Citation": "Chen X, Xu R, He D, Zhang Y, Chen H, Zhu Y, Cheng Y, Liu R, Zhu R, Gong L, Xiao M, Wang Z, Deng L, Cao K. CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer. Oncogene. 2021; 40:6223\u201334. 10.1038/s41388-021-02019-6", "ArticleIdList": ["10.1038/s41388-021-02019-6", "34552192"]}, {"Citation": "Zhou F, Qiao M, Zhou C. The cutting-edge progress of immune-checkpoint blockade in lung cancer. Cell Mol Immunol. 2021; 18:279\u201393. 10.1038/s41423-020-00577-5", "ArticleIdList": ["10.1038/s41423-020-00577-5", "PMC8027847", "33177696"]}, {"Citation": "Chowell D, Yoo SK, Valero C, Pastore A, Krishna C, Lee M, Hoen D, Shi H, Kelly DW, Patel N, Makarov V, Ma X, Vuong L, et al.. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. Nat Biotechnol. 2022; 40:499\u2013506. 10.1038/s41587-021-01070-8", "ArticleIdList": ["10.1038/s41587-021-01070-8", "PMC9363980", "34725502"]}, {"Citation": "Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, et al.. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018; 24:1550\u20138. 10.1038/s41591-018-0136-1", "ArticleIdList": ["10.1038/s41591-018-0136-1", "PMC6487502", "30127393"]}, {"Citation": "Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021; 22:bbab260. 10.1093/bib/bbab260", "ArticleIdList": ["10.1093/bib/bbab260", "PMC8574972", "34260682"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "1"}, {"Year": "2023", "Month": "12", "Day": "26"}, {"Year": "2024", "Month": "4", "Day": "8", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "3", "Day": "19", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "3", "Day": "18", "Hour": "21", "Minute": "33"}, {"Year": "2024", "Month": "3", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38499392", "PMC11006486", "10.18632/aging.205668", "205668"]}}]}